Stock comparison
BioMarin Pharmaceutical
BMRN$11.44BHealthcare Market cap, Sector
Camurus AB (publ)
CAMX.ST$36.93BHealthcare Market cap, Sector
Overall winner
Camurus AB (publ)
BMRN 07 CAMX.ST
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
BMRN0wins
7winsCAMX.ST
54D
B78
53D
A91
51D
A94
43F
C65
24F
C63
41F
B77
48D
B77
Side-by-side metrics
| Metric | BMRN | CAMX.ST |
|---|---|---|
| Market cap | $11.44B | $36.93B Winner |
| P/E (TTM) | Winner: 38.7x | 42.6x |
| EV/EBIT | Winner: 18.1x | 29.5x |
| ROIC (TTM) | 3.92% | 17.17% Winner |
| Gross margin | 75.93% | 93.11% Winner |
| Net margin | 8.29% | 32.47% Winner |
| Revenue CAGR 5y | 14.93% | 33.3% Winner |
| EPS CAGR 5y | Winner: 2.29% | 132.79% |
| Debt / Equity | 0.2x | 0.0x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BMRN leads on
- EPS CAGR 5y2.29%vs 132.79%+42%
- EV/EBIT18.1xvs 29.5x+39%
- P/E (TTM)38.7xvs 42.6x+9%
CAMX.ST leads on
- Debt / Equity0.0xvs 0.2x+89%
- ROIC (TTM)17.17%vs 3.92%+77%
- Net margin32.47%vs 8.29%+74%
- Market cap$36.93Bvs $11.44B+69%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.